TMCnet News
Check Out Stock Marketing Inc Today!! IWEB,ZVTK,APRO,LMCO,ONCI,ADXS:: Sign Up Today!!(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (OTCBB: IWEB) IceWEB, Inc., (OTCBB: ZVTK) Zevotek, Inc., (OTCBB: APRO) Allegiant Professional Business Services, Inc., (OTCBB: LMCO) Li-ion Motors Corp., (OTCBB: ONCI) On4 Communications, Inc., (OTCBB: ADXS) Advaxis, Inc. www.StockMarketingInc.com For More Information email us!! [email protected] ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: IWEB - IceWEB, Inc.) LATEST NEWS!! IceWEB Expands West Coast Operations Due To Thriving Demand for IceWEB 5000 Systems in the Channel Company Brings on Former Senior Sun Microsystems Architect STERLING, Va., May 3, 2010 -- IceWEB(TM), Inc. (OTC Bulletin Board: IWEB), www.IceWEB.com, a leading provider of Unified Data Storage and building blocks for cloud storage networks, announced today that it has added depth to its technology team with the addition of technology veteran Mr. Bryan Brooks. Mr. Brooks will handle West Coast engineering. Over the last 11 years Mr. Brooks served as a senior solution architect for Sun Microsystems, Inc. where he was responsible for a broad variety of technologies including communications and collaboration software, web and application infrastructure, virtual desktop infrastructure, and identity and access management. He has delivered solutions for clients across North America from a variety of industries including finance, telecommunications, manufacturing, government, healthcare, and higher education. "This is a perfect situation to come in at an early stage and take the IceWEB 5000 to the next level," stated, Bryan Brooks, West Coast Engineering Manager, IceWEB. "As we build our footprint, it will be critical to ensure the customer is 100 percent satisfied with the delivery of our unified storage system. I am already deeply engaged with both the engineering and sales teams on several revenue generating opportunities." Dave Skinner, IceWEB SVP of Engineering, stated, "We have the foundation of a world-class engineering team that is capable of delivering and driving sales to the next level in the data storage space. Our platform is built on open source, so having a longtime Sun Microsystems architect on our team certainly enhances our ability to lead the way in Unified Data Storage on a 128bit open file system." About IceWEB, Inc. Headquartered just outside of Washington, D.C., IceWEB manufactures and markets purpose built appliances, network and cloud storage solutions and delivers on-line cloud computing application services. Its customer base includes U.S. government agencies, enterprise companies, and small to medium sized businesses (SMB). For more information, please visit www.IceWEB.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: ZVTK - Zevotek, Inc.) LATEST NEWS!! Zevotek Announces OTCBB Listing NEW YORK, May 3, 2010 -- Zevotek, Inc., (OTCBB: ZVTK), a worldwide direct marketer and distributor of innovative personal and home care items, today announced that the Company's shares are once again listed on the OTCBB. Market maker Spartan Securities Group, Ltd. received notice from FINRA (Financial Industry Regulatory Authority) that Spartan's April 27, 2010 application for OTCBB listing of Zevotek common stock was cleared effective April 30, 2010. Last week, Zevotek announced that its shares started listing on the OTCQB, a newly created OTCBB competitor for stocks of U.S. registered and reporting companies that are current on their reporting to the SEC. Spartan and other market makers recently chose to make markets in Zevotek shares and other OTC companies on the OTCQB, where maintaining listings is less costly for market makers. Commenting on the announcement, Zevotek's CEO, Rob Babkie, said, "We greatly appreciate the swift action taken by Spartan Securities and FINRA to clear Zevotek's OTCBB listing. I am pleased that Zevotek investors today can see their shares trading on the familiar OTCBB. The OTC marketplace is undergoing changes that are independent of Zevotek's business. I remain committed to maintaining Zevotek's status as a fully reporting public company whose stock trades on a leading OTC exchange." About the Company: Zevotek, Inc. plans to market and sell a range of innovative personal and home care items. Zevotek has a license to sell an energy saving compact fluorescent light bulb (CFL) named the Ionic Bulb, a light bulb designed for consumer use by combining the performance features of ionic air cleaning technology with those of a 10,000 hour reduced energy use compact fluorescent light bulb (CFL).The Company sells the Ionic Bulb through TV infomercials and the Internet and plans to market Ionic Bulbs through catalogs, magazines and major U.S. retail and specialty stores. The Company's 1 minute and 2 minute Ionic Bulb TV ads are designed to air on national cable channels, local broadcast channels and TV superstations. Zevotek directly sells the Ionic Bulb to consumers through http://www.newionicbulb.com ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: APRO - Allegiant Professional Business Services, Inc.) LATEST NEWS!! APRO Predicts Gross Billings to Exceed $144 Million in Calendar 2009; Changes Fiscal End Year to December 31 MARLTON, N.J., May 3, 2010 -- Allegiant Professional Business Services, Inc. (OTC Bulletin Board: APRO) said today that it is poised to report projected gross billings of $144 million for calendar year 2009. In accordance with GAAP and subject to audit, APRO projects reportable revenues of $47 million. The company has also changed its fiscal year end to December 31. CEO David Goldberg said that he is pleased with the preliminary figures on the 2009 performance and that 2010 also looks robust in sales and operations. In other news, APRO announced today that it has completed its financial records audit for the three-month period ending December 31, 2008. Allegiant will report revenues of $1,162,838 and a net loss of $1,558,499. Due to the late filing of its Form 10K for this reporting period, workers' compensation liabilities were included through April 25, 2010, as such amounts were known as of the date of this release. This resulted in a charge to earnings of $1,064,000. The charges would not have been reportable as of the timely date for the conclusion of audit work. The resultant net loss would have been $494,499. Allegiant expects to file its Form 10K within three weeks. Management is now working on closing the subsequent quarters of 2009 and hopes to be caught up with all financial filings by August 14, 2010. Regarding the 2008 results, Goldberg said the problems of start up and consolidation of systems and procedures has been completed and looks forward to continuing improvement in the Company's performance in the future periods. Allegiant Professional Business Services, Inc. provides staffing and PEO services to small and medium-size businesses, relieving our clients from many of the day-to-day tasks that negatively impact their core business operations, such as payroll processing, human resources support, workers' compensation insurance, safety programs, employee benefits, and other administrative and aftermarket services predominantly related to staffing -- staff leasing, temporary staffing and co-employment. We not only provide core services but a wide selection of employee and employer benefits and aftermarket products. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: LMCO - Li-ion Motors Corp.) LATEST NEWS!! Li-ion Motors Corp. Plays Its Part in the Future of Advanced Transportation MOORSEVILLE, N.C., May 03, 2010 -- Li-ion Motors Corp. (OTCBB: LMCO) www.Li-ionMotors.com, 21st Century Design & Engineering of emission-free automotive propulsion systems using the latest lithium-ion battery technology, is pleased to announce its participation in a one week shakedown event of technical inspections, safety inspections, durability testing and efficiency runs at the Michigan speedway. Click on this link to view Li-ion Motors Wave II. Li-ion Motors featured the revolutionary Wave at the Detroit Auto Show, displaying groundbreaking developments the company has made on their emissions free vehicles. Li-ion Motors feels their breakthrough will help change the way the world looks at the automobile and vehicle construction today. From overall electrical engineering to space-age materials, futuristic aerodynamics and a new standard for safety, the company is prominently positioned and ready for the competition. The X-PRIZE competition is intended to inspire a new generation of viable, super fuel-efficient vehicles that offer more consumer choices. Li-ion Motors' entry into the X-Prize is an Electric vehicle (EV), powered by Lithium-ion batteries. LMCO's entry is not a hybrid car; it is a true electric car. Li-ion Motors is an electric vehicle manufacture, producing lithium-powered vehicles including electric mopeds, sports vehicles, and electric motorcycles in addition to the electric cars. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: ONCI - On4 Communications, Inc.) LATEST NEWS!! On4(TM) Continues on Track to Meet Business Targets SCOTTSDALE, AZ, April 30, 2010 -- On4(TM) Communications, Inc. (OTCBB: ONCI) announces the company is on target to meeting its 2010 business targets for revenue and debt reduction. On4(TM) Communications President and CEO Cameron Robb, says, "Overall, we are very pleased with both the effort and progress the company has made year to date. A lot of hard work has been done in moving On4 from a development stage company to one which is ready for operational reoccurring revenue." So far, this year, On4(TM) has announced; - an exclusive licensing agreement deal that enables On4(TM) to provide broad based GPS hardware and software solutions surrounding the tracking, locating and monitoring of people, property and animals and, - the roll out of its LBS vehicle tracking service with National Cash and Credit and, - the company has also eliminated approximately $1,050,00 in debt from its balance sheet and is working on eliminating a further $600,000. In a market that analysts expect will see exceptional growth, and with North America predicted to lead the growth, the demand for Location Based Services (LBS) will be very robust. According to the research firm, Gartner, Inc. a LBS sector research firm, "that only 5 to 20% of the targeted audience for LBS has been tapped and that mainstream adoption will occur by 2012." As Mr. Robb has said, "The company's business plan is to grow revenues both organically and through acquisitions and we believe that through the agreements we now have in place, and those that the company will soon be entering into, along with the debt reduction, the company is in an exceptional position to rapidly gain market share." About On4(TM) On4(TM) Communications is a globally diversified Location Based Services (LBS) company with offices in Scottsdale, Arizona; in Richmond, British Columbia and representation in China. On4(TM) is a leading provider of Public Safety, Personal Asset and Healthcare location based asset tracking and monitoring services. The company is currently in the process of designing, developing, and marketing personal LBS devices that are intended to provide tracking and location monitoring for people, animals and property of any other nature. Specific applications may include offender monitoring, elderly, medical, teens and children tracking, public safety officers, executives, cars, tracks, motorcycles, aircraft, boats, personal watercraft, ATVs, equipment, cargo, tools, trailers, electronic equipment, retail goods, and consumer goods in transit. On4(TM) will utilize numerous technologies, including but not limited to CDMA, GSM, GPS, E911, A-GPS, radio frequency and beacon technology. On4(TM)'s leading edge technology leverages global positioning system satellites and wireless technology enabling its network of members to locate anyone or anything to which our device is attached in real time. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: ADXS - Advaxis, Inc.) LATEST NEWS!! Advaxis to Host Investigators Meeting for ADXS11-001 Cervix Cancer Trial in Mumbai, India Twenty of India's Leading Oncologists to Attend | Meetings Set for May 7 -- 8, 2010 NORTH BRUNSWICK, N.J., May 03, 2010 -- Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, will host an investigator's meeting in Mumbai, India with twenty (20) of the country's leading oncologists. The meeting is set for May 7-8, 2010 and will help prepare for the initiation of a multicenter study of their lead compound, ADXS11-001 for the treatment of advanced, metastatic cervix cancer in women who have failed cytotoxic therapy. Investigators from Apollo Hospitals Research Foundation, Tata Memorial Centre, Chittaranjan National Cancer Institute and other sites of clinical excellence will discuss Advaxis' work, the experimental protocol to be conducted and the execution of the clinical trial. "Cervix cancer is a leading cause of mortality in Indian women," said Advaxis Executive VP of Science and Operations Dr. John Rothman. "If the efficacy signal we observed in our Phase 1 study in this patient population is repeated in this larger study, then ADXS11-001 may represent an important agent for the treatment of a disease state for which no effective therapy currently exists. We will also be investigating the use of our immunotherapy in combination with chemotherapy in this trial. Combining immune and cytotoxic treatments is a very interesting and important area of contemporary cancer research." Later during the week, Dr. John Rothman will lecture at the Chitteranjan National Cancer Institute and Chhatrapati Shahuji Maharaj Medical University --formerly, King George's Medical University. About the ADXS11-001 Immunotherapy ADXS11-001 is a therapeutic vaccine that treats human papilloma virus (HPV) related tumors. Unlike marketed prophylactic vaccines that require treatment prior to exposure to the virus, ADXS11-001 treats patients who have already developed cancer as a result of HPV infection. Today, HPV is the most prevalent sexually transmitted disease in the US and the cause of cervix cancer, 40% of head and neck cancer, as well as penile, vulvar and anal cancer. Other clinical trials are planned for this agent in 2010 including a trial in cervical intraepithelial neoplasia (CIN), and oropharyngeal head and neck cancer. About The Advaxis Phase I Clinical Trial This Phase I clinical trial was conducted in women with advanced cervix cancer that had progressed following cytotoxic therapy. In most cases, these women had been treated with multiple therapeutic modalities including surgery, radiation and chemotherapy. It is accepted that once these patients fail cytotoxic therapy there is little that can be offered to cure their disease or extend life. Historically, the median survival for these patients is approximately 180 days with only about 5% surviving one year. In the Advaxis Phase I clinical trial, the median survival was 347 days with 57% of patients surviving one year. More information on this clinical trial can be found in the published results of this trial (Vaccine 27 2009 3975--3983). About Advaxis, Inc. Advaxis is a biotechnology company developing proprietary, live, attenuated Listeria monocytogenes (Listeria) immunotherapeutics that deliver engineered tumor antigens, which stimulate multiple, simultaneous, immunological mechanisms to fight cancer. Today, the Company has nine (9) distinct, cancer-fighting constructs in various stages of development, directly and through strategic collaborations with such recognized sites of excellence as the City of Hope, the Roswell Park Cancer Institute, the National Cancer Institute, the University of Pittsburgh and Cancer Research -- UK. The Company's technology was developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania and chairperson of Advaxis' scientific advisory board. Please visit the Company's portals: advaxis.com ------------------------------------------------------------------------------------------------------------------------------------------------------------ About StockMarketingInc.com StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed. ((Comments on this story may be sent to [email protected])) (c) 2010 M2 COMMUNICATIONS |